Lipophilicity and Other Parameters Affecting Brain Penetration
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
229-240
Author(s):
F. Atkinson, S. Cole, C. Green and H. van de Waterbeemd
Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Journal:
Current Genomics
Volume:
3
Page:
245-263
Author(s):
S. Ortega, M. Malumbres and M. Barbacid
ras Genes and Human Cancer: Different Implications and Different Roles
Journal:
Current Genomics
Volume:
3
Page:
295-311
Author(s):
Jose M. Rojas and Eugenio Santos
Epithelial-Mesenchymal Transitions and Cancer
Journal:
Current Genomics
Volume:
3
Page:
355-361
Author(s):
Ethan A. Carver and Thomas Gridley
Genetics of Cancer Susceptibility
Journal:
Current Genomics
Volume:
3
Page:
379-388
Author(s):
Rogelio Gonzalez-Sarmiento
Tumour Cytochrome P450 and Drug Activation
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1335-1347
Author(s):
Laurence H. Patterson and Graeme I. Murray
Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
441-463
Author(s):
Michel Demeule, Jonathan Michaud-Levesque, Borhane Annabi, Denis Gingras, Dominique Boivin, Julie jodoin, Sylvie Lamy, Yanick Bertrand and Richard Beliveau
Rational Design of 5-Aminolevulinic Acid Derivatives Aimed at Improving Photodynamic Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
465-475
Author(s):
Adriana Casas and Alcira Batlle
Histone Deacetylase Inhibitors and Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
477-484
Author(s):
G. Kouraklis and S. Theocharis
Novel Concepts in the Development of Platinum Antitumor Drugs
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
539-551
Author(s):
M. A. Fuertes, J. Castilla, C. Alonso and J. M. Perez